Browser Not Supported.

IE users: please get the latest browser version at Microsoft Internet Explorer Home Page

if yot already have the latest browser version please verify that your browser settings is not in compatibility mode

Browser: unknown
Version: 0

EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content

Welcome to
LifeMap Discovery

Watch the introductory video to learn more about our database of embryonic development for stem cell research and regenerative medicine

All in Vitro Cells > Induced Pluripotent Stem Cell card

Reprogrammed amyotrophic lateral sclerosis cells (Harvard Stem Cell Institute)

Induced pluripotent stem cells (iPSC) were generated from skin fibroblasts of a patient diagnosed with a familial form of amyotrophic lateral sclerosis (ALS), that carries a gene mutation, L144F, in the superoxide dismutase (SOD1) gene, and from skin fibroblasts of her sister, who carries the same gene mutation but is clinically asymptomatic. 
The cells were reprogrammed, by viral transfection, with retroviruses encoding  KLF4, SOX2, OCT4, and c-MYC. The iPSCs were characterized and directly differentiated into motoneurons.


Cells are cultured in DMEM/F12 medium, supplemented with knock out serum replacement (20%), Glutamax-l (2mM), minimum essential medium (MEM) non essential amino acids (1%), penicillin/streptomycin (50 U/mL), 2-mercaptoethanol (0.055mM), basic-fibroblast growth factor (5 ng/mL), human leukemia inhibitory factor (12 ng/mL), and supported by an inactivated mouse embryonic fibroblast (MEF) feeder layer.

See additional Stem, Progenitor & Primary Cells for: Inner Cell Mass
Induced Pluripotent Stem Cell
Human
Reprogrammed amyotrophic lateral sclerosis cells